news

Congratulation to Teena Bajaj and Babak Mosavati for their recent publication in RSC Advance titled “Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning”

Congratulation to Teena Bajaj and Babak Mosavati for their recent publication in RSC Advance titled “Identification of acrylamide-based covalent inhibitors of SARS-CoV-2 (SCoV-2) Nsp15 using high-throughput screening and machine learning” Read More »

Congratulation to Hesong Han and Sheng Zhao for the recent publication in Nature Biomedical Engineering titled “A microphysiological system for screening lipid nanoparticle−mRNA complexes predicts in vivo heart transfection efficacy”

Congratulation to Hesong Han and Sheng Zhao for the recent publication in Nature Biomedical Engineering titled “A microphysiological system for screening lipid nanoparticle−mRNA complexes predicts in vivo heart transfection efficacy” Read More »

Brain Delivery of CRISPR-Gold Published in Nature Biomedical Engineering!

The Murthy Lab, along with collaborators in Hye Young Lee’s lab at the University of Texas, San Antonio, has published the paper “Nanoparticle delivery of CRISPR into the brain rescues a mouse model of fragile X syndrome from exaggerated repetitive behaviours” in Nature Biomedical Engineering. In the paper, we demonstrate that our previously developed CRISPR-Gold gene editing delivery

Brain Delivery of CRISPR-Gold Published in Nature Biomedical Engineering! Read More »

Murthy lab research on CRISPR-Gold published in Nature Biomedical Engineering

Murthy lab research on CRISPR-Gold published in Nature Biomedical Engineering.  The paper was titled “Nanoparticle delivery of Cas9 ribonucleoprotein and donor DNA in vivo induces homologous directed DNA repair”.  In this paper we demonstrate that it is possible to correct DNA mutations in vivo by delivering the Cas9 protein, guide RNA and donor DNA with

Murthy lab research on CRISPR-Gold published in Nature Biomedical Engineering Read More »

Scroll to Top